FDA Approved: ERIBULIN MESYLATE — Original Application (Dr. Reddys Laboratories Inc)

View source ↗

Summary

FDA approves Dr. Reddy's Laboratories' original ANDA for eribulin mesylate, a generic version of the anticancer agent.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Liposarcoma

Drugs mentioned

• ERIBULIN MESYLATE (Eribulin mesylate)

Snippet

ORIG AP for ERIBULIN MESYLATE (ERIBULIN MESYLATE)